Blue Earth Therapeutics will leverage Shine's non-carrier added lutetium-177 chloride, Ilumira, in a new treatment for prostate cancer undergoing clinical trials
WARF Therapeutics is taking a unique-to-Wisconsin approach to anchoring an emerging medical industry within a 100-mile radius of the state Capitol. The benefits are potentially immense.
Wisconsin has a competitive advantage in fusion research, with the University of Wisconsin-Madison s Fusion Technology Institute producing 167 Ph.D. graduates in fusion engineering. Private investment in the fusion market is expected to grow as the world seeks clean energy options.
FiNext Conference 2024 wraps up its 6th edition with success khaleejtimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from khaleejtimes.com Daily Mail and Mail on Sunday newspapers.
Former United States Speaker of the House and former vice presidential nominee Paul Ryan visited OU’s Norman campus on Wednesday, telling students to engage with their communities and protect democracy.